Scaling-up Packages of Interventions for Cardiovascular Disease Prevention in Selected Sites in Europe and Sub-Saharan Africa: An Implementation Research

NCT03154736 | Completed

• 1 other identifier: 29BRC17.0015 SPICES_PHASE_1
• Study Type: interventional
• Target: 56
• Locations: 1 country
• Sites: 21

Brief Summary

Cardiovascular disease is the leading cause of death in the world. 17.5 million people died in 2012 due to a cerebrovascular disease (31% of all causes of death). In Europe more than 50% of deaths are due to cardiovascular disease. The mortality rate for cardiovascular disease is higher in the lower socio-economic levels. Three-quarters of deaths from cardiovascular disease occur in developing countries. According to estimates in 2030, cardiovascular disease will be responsible for more deaths than the sum of infectious, nutritional, maternal and perinatal diseases in developing countries. Measures to prevent cardiovascular risk factors have been shown to be effective. The lack of an adequate primary care network in developing countries limits the screening and treatment of patients with cardiovascular risk factors. As a result, these patients do not benefit from adequate prevention, are diagnosed late and remain disabled or die at a young age, resulting in significant additional costs for families but also at the macroeconomic level. Interventions are possible on a large scale (policies against tobacco and adverse dietary behavior, promote physical activity, etc.). Actions are possible on an individual level, both in primary prevention (control of cardiovascular risk factors) and secondary prevention, where many treatments have proved their effectiveness. These interventions are effective and cost-effective from a macroeconomic perspective. It was estimated that the cost of such interventions would not exceed 4% of health expenditure in developing countries and 1-2% in rich countries. The World Health Organization insists on the importance of the triad composed by the patient and his family, community and health professionals. Results are possible only when these three components work together for the same purpose. Numerous studies show the benefit of the involvement of patients in their care in the rich countries and in the developing countries.

Conditions

Cardiovascular Disease

Keywords

CVD; FDRCV; Developing countries; Rcih countries

Outcome Measures

Primary Outcomes (1)

• Experiences of patients with cardiovascular disease

  The representations on cardiovascular prevention and the follow-up experience of patients with cardiovascular disease or CVRF will be defined by questionnaire

  1 day

Secondary Outcomes (3)

• The obstacles of patients with cardiovascular disease

  1 day

• Institutional care network

  1 day

• Informal or informal care network

  1 day

Study Arms (1)

Interview

EXPERIMENTAL

Individual interview an in a group interview. Socio-economic questionnaire

Other: Interview

Interventions

Interview OTHER

Individual interview and group interview Socio-economic questionnaire

Interview

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Persons aged over 18 years.
• Persons able to express their consent
• Patients with FDRCV or CVD who gave written consent to participate in the study.
• Family caregiver of patients with FDRCV or CVD with written consent to participate in the study

You may not qualify if:

• Refusal to participate in the study
• Patients and / or family caregiver who can not express their consent (illiterate, severe cognitive or psychiatric disorders)
• Patients under judicial protection (guardianship and curatorship)
• Pregnant women
• Patients under 18 years of age

Sponsors & Collaborators

• University Hospital, Brest: lead
• ERCR SPURBO: collaborator

Study Sites (21)

Carhaix Plouguer

Carhaix-Plouguer, France

Location

Chateauneuf du Faou

Châteauneuf-du-Faou, France

Location

Coray

Coray, France

Location

Guémené-sur-Scorff

Guémené-sur-Scorff, France

Location

Guiscriff

Guiscriff, France

Location

La Chapelle Thouarault

La Chapelle-Thouarault, France

Location

Landeleau

Landeleau, France

Location

Laniscat

Laniscat, 22570, France

Location

LAZ

Laz, France

Location

Le Faouet

Le Faouët, France

Location

Nevez

Névez, France

Location

Plonevez du faou

Plonévez-du-Faou, France

Location

Plonévez du Faou

Plonévez-du-Faou, France

Location

Plounevez-Quintin

Plounévez-Quintin, France

Location

Plouray

Plouray, 56770, France

Location

Poullaouen

Poullaouen, France

Location

Rostrenen

Rostrenen, France

Location

Roudouallec

Roudouallec, France

Location

Saint Nicolas du Pelem

Saint-Nicolas-du-Pélem, France

Location

Spezet

Spézet, France

Location

Tregourez

Trégourez, France

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Interviews as Topic

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 11, 2017
• First Posted: May 16, 2017
• Study Start: October 2, 2017
• Primary Completion: February 28, 2019
• Study Completion: February 28, 2019
• Last Updated: April 4, 2019

Record last verified: 2019-04

Data Sharing

• IPD Sharing: Will not share

Locations

FR (21)